The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma

BACKGROUND: Body composition is an important predictor of drug toxicity and outcome. Ipilimumab (Ipi), a monoclonal antibody used to treat metastatic melanoma, has specific toxicities. No validated biomarkers that predict Ipi toxicity and efficacy exist. Also, the impact of Ipi on body composition h...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, Louise E, Power, Derek G, O'Reilly, Áine, Donnellan, Paul, Cushen, Samantha J, O'Sullivan, Kathleen, Twomey, Maria, Woodlock, David P, Redmond, Henry P, Ryan, Aoife M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294486/
https://www.ncbi.nlm.nih.gov/pubmed/28072766
http://dx.doi.org/10.1038/bjc.2016.431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294486/
https://www.ncbi.nlm.nih.gov/pubmed/28072766
http://dx.doi.org/10.1038/bjc.2016.431

Ejemplares similares